EDGAR Filing Documents for 0001193125-19-173808

Form 8-K12B - Notification that a class of securities of successor issuer is deemed to be registered pursuant to section 12(b):

SEC Accession No. 0001193125-19-173808

Filing Date

2019-06-14

Accepted

2019-06-14 17:10:54

Documents

Period of Report

2019-06-12

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K12B	d826633d8k12b.htm	8-K12B	71236
2	EX-10.1	d826633dex101.htm	EX-10.1	58359
3	EX-10.2	d826633dex102.htm	EX-10.2	58426
4	EX-10.3	d826633dex103.htm	EX-10.3	57007
5	EX-10.4	d826633dex104.htm	EX-10.4	197941
6	EX-14.1	d826633dex141.htm	EX-14.1	41172
7	EX-99.1	d826633dex991.htm	EX-99.1	5816
8	GRAPHIC	g826633dsp88a.jpg	GRAPHIC	4246
9	GRAPHIC	g826633dsp88b.jpg	GRAPHIC	7134
	Complete submission text file	0001193125-19-173808.txt		507558

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121

Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660

Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)